Advertisement

Topics

Apotex's Neulasta, Neupogen Biosimilars Clear Legal Hurdles, But Approval Questions Remain

12:41 EST 14 Nov 2017 | Elsevier Business Intelligence

Federal appeals court affirms ruling that Apotex's biosimilars do not infringe Amgen's manufacturing process patent, ...

Original Article: Apotex's Neulasta, Neupogen Biosimilars Clear Legal Hurdles, But Approval Questions Remain

NEXT ARTICLE

More From BioPortfolio on "Apotex's Neulasta, Neupogen Biosimilars Clear Legal Hurdles, But Approval Questions Remain"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...